Sequence ID | Evalue | Region | Family |
232600 | 2.75e-24 | 338-573 | Nuclear receptor ligand-binding domain |
232601 | 0.000000000155 | 337-479 | Nuclear receptor ligand-binding domain |
944 | 1.57e-23 | 2-105 | Nuclear receptor ligand-binding domain |
AAA93297 | 8.1e-32 | 176-265,420-549 | Nuclear receptor ligand-binding domain |
AAA96057 | 9.44e-33 | 303-551 | Nuclear receptor ligand-binding domain |
AAA96982 | 6.03e-31 | 251-491 | Nuclear receptor ligand-binding domain |
AAA96983 | 9.44e-33 | 303-551 | Nuclear receptor ligand-binding domain |
AAA96984 | 2.75e-24 | 338-573 | Nuclear receptor ligand-binding domain |
AAC77795 | 6.42e-31 | 251-491 | Nuclear receptor ligand-binding domain |
AAD03681 | 1.84e-41 | 253-488 | Nuclear receptor ligand-binding domain |
AAD03682 | 2.75e-24 | 338-573 | Nuclear receptor ligand-binding domain |
AAD03683 | 0.000000199 | 206-381 | Nuclear receptor ligand-binding domain |
AAD03684 | 7.21e-28 | 318-558 | Nuclear receptor ligand-binding domain |
AAD03689 | 4.68e-34 | 141-384 | Nuclear receptor ligand-binding domain |
AAD34462 | 6.95e-18 | 362-397,539-750 | Nuclear receptor ligand-binding domain |
AAD34463 | 5.64e-18 | 303-338,480-691 | Nuclear receptor ligand-binding domain |
AAD34464 | 6.16e-19 | 35-264 | Nuclear receptor ligand-binding domain |
AAD55066 | 0.00000000000288 | 169-320 | Nuclear receptor ligand-binding domain |
C02B4.2 | 7.47e-38 | 158-386 | Nuclear receptor ligand-binding domain |
C03G6.10 | 1.84e-37 | 156-355 | Nuclear receptor ligand-binding domain |
C03G6.8 | 4.98e-39 | 151-378 | Nuclear receptor ligand-binding domain |
C05G6.1 | 5.77e-33 | 85-310 | Nuclear receptor ligand-binding domain |
C06B8.1 | 9.66e-21 | 149-337 | Nuclear receptor ligand-binding domain |
C06C6.4 | 0.00000000000000319 | 129-348 | Nuclear receptor ligand-binding domain |
C06C6.5A | 0.0000000000000322 | 172-344 | Nuclear receptor ligand-binding domain |
C06G3.1 | 5.79e-32 | 131-422 | Nuclear receptor ligand-binding domain |
C08F8.8 | 0.00000000047 | 92-305 | Nuclear receptor ligand-binding domain |
C11G6.4 | 3.18e-43 | 123-373 | Nuclear receptor ligand-binding domain |
C12D5.2 | 8e-39 | 172-359 | Nuclear receptor ligand-binding domain |
C13C4.1 | 9.83e-44 | 195-392 | Nuclear receptor ligand-binding domain |
C17A2.1 | 2.49e-21 | 124-326 | Nuclear receptor ligand-binding domain |
C17E7.1 | 0.00000177 | 146-205 | Nuclear receptor ligand-binding domain |
C17E7.8 | 2.75e-39 | 131-370 | Nuclear receptor ligand-binding domain |
C26B2.3 | 2.75e-42 | 230-466 | Nuclear receptor ligand-binding domain |
C26B2.4 | 4.98e-26 | 164-367 | Nuclear receptor ligand-binding domain |
C27C7.3 | 8.67e-18 | 133-313 | Nuclear receptor ligand-binding domain |
C27C7.8 | 3.37e-21 | 2-174 | Nuclear receptor ligand-binding domain |
C29E6.5 | 7.58e-17 | 230-428 | Nuclear receptor ligand-binding domain |
C29F9.13 | 3.87e-21 | 43-140 | Nuclear receptor ligand-binding domain |
C33G8.10 | 9.79e-22 | 124-337 | Nuclear receptor ligand-binding domain |
C33G8.12 | 2.78e-16 | 165-341 | Nuclear receptor ligand-binding domain |
C33G8.6 | 5.49e-25 | 106-350 | Nuclear receptor ligand-binding domain |
C33G8.8 | 1.47e-18 | 120-341 | Nuclear receptor ligand-binding domain |
C33G8.9 | 7.62e-23 | 132-332 | Nuclear receptor ligand-binding domain |
C38C3.9 | 5.77e-41 | 166-396 | Nuclear receptor ligand-binding domain |
C41G6.5 | 0.0000000000000219 | 194-364 | Nuclear receptor ligand-binding domain |
C45E5.6 | 8.91e-38 | 278-524 | Nuclear receptor ligand-binding domain |
C47F8.2 | 1.42e-16 | 170-315 | Nuclear receptor ligand-binding domain |
C47F8.8 | 1.46e-18 | 135-345 | Nuclear receptor ligand-binding domain |
C49D10.2 | 1.7e-38 | 136-355 | Nuclear receptor ligand-binding domain |
C49D10.6 | 1.71e-23 | 124-341 | Nuclear receptor ligand-binding domain |
C54C8.1 | 1.16e-24 | 160-354 | Nuclear receptor ligand-binding domain |
C54E10.5 | 2.87e-35 | 170-419 | Nuclear receptor ligand-binding domain |
C54F6.8 | 3.15e-40 | 115-347 | Nuclear receptor ligand-binding domain |
C56E10.4 | 3.11e-27 | 55-101,160-355 | Nuclear receptor ligand-binding domain |
E02H1.7 | 2.36e-41 | 245-475 | Nuclear receptor ligand-binding domain |
E02H9.8 | 4.72e-35 | 189-452 | Nuclear receptor ligand-binding domain |
F08D12.14 | 5.24e-30 | 179-372 | Nuclear receptor ligand-binding domain |
F10G2.9 | 0.0000000000263 | 11-80 | Nuclear receptor ligand-binding domain |
F14A5.1 | 8.44e-23 | 202-386 | Nuclear receptor ligand-binding domain |
F14H3.11 | 7.14e-22 | 94-331 | Nuclear receptor ligand-binding domain |
F16B12.8 | 2.26e-38 | 120-358 | Nuclear receptor ligand-binding domain |
F16B4.1 | 1.05e-25 | 177-418 | Nuclear receptor ligand-binding domain |
F16B4.11 | 1.53e-26 | 204-428 | Nuclear receptor ligand-binding domain |
F16B4.12A | 1.52e-30 | 191-431 | Nuclear receptor ligand-binding domain |
F16B4.9 | 1.1e-28 | 170-420 | Nuclear receptor ligand-binding domain |
F21D12.1B | 1.57e-22 | 166-395 | Nuclear receptor ligand-binding domain |
F25E5.6 | 9.7e-18 | 161-283 | Nuclear receptor ligand-binding domain |
F31F4.12 | 1.31e-40 | 159-394 | Nuclear receptor ligand-binding domain |
F32B6.1 | 1.84e-41 | 253-488 | Nuclear receptor ligand-binding domain |
F33E11.1 | 6.98e-52 | 131-369 | Nuclear receptor ligand-binding domain |
F35E8.12 | 1.75e-21 | 95-332 | Nuclear receptor ligand-binding domain |
F36A4.14 | 6.29e-27 | 162-364 | Nuclear receptor ligand-binding domain |
F36D3.2 | 1.03e-34 | 166-421 | Nuclear receptor ligand-binding domain |
F38H12.3 | 1.97e-42 | 189-404 | Nuclear receptor ligand-binding domain |
F41B5.10 | 2.89e-33 | 168-393 | Nuclear receptor ligand-binding domain |
F41D3.1 | 1.87e-20 | 113-321 | Nuclear receptor ligand-binding domain |
F43C1.4 | 1.57e-33 | 200-452 | Nuclear receptor ligand-binding domain |
F44A6.2A | 6.03e-31 | 251-491 | Nuclear receptor ligand-binding domain |
F44C4.2 | 1.87e-24 | 172-414 | Nuclear receptor ligand-binding domain |
F44C8.10 | 2.18e-37 | 157-402 | Nuclear receptor ligand-binding domain |
F44C8.11 | 1.27e-33 | 158-400 | Nuclear receptor ligand-binding domain |
F44C8.2 | 2.05e-37 | 161-405 | Nuclear receptor ligand-binding domain |
F44C8.3 | 1.26e-37 | 147-393 | Nuclear receptor ligand-binding domain |
F44C8.4 | 1.24e-38 | 168-392 | Nuclear receptor ligand-binding domain |
F44C8.6 | 2.42e-36 | 162-405 | Nuclear receptor ligand-binding domain |
F44C8.8 | 5.84e-35 | 184-404 | Nuclear receptor ligand-binding domain |
F44C8.A | 2.42e-36 | 162-405 | Nuclear receptor ligand-binding domain |
F44E7.8 | 2.21e-35 | 172-407 | Nuclear receptor ligand-binding domain |
F44G3.9 | 0.000000104 | 162-303 | Nuclear receptor ligand-binding domain |
F47C10.1 | 2.62e-40 | 123-375 | Nuclear receptor ligand-binding domain |
F47C10.3 | 2.1e-50 | 130-366 | Nuclear receptor ligand-binding domain |
F47C10.4 | 3.54e-44 | 123-353 | Nuclear receptor ligand-binding domain |
F47C10.7 | 2.75e-44 | 116-350 | Nuclear receptor ligand-binding domain |
F48G7.11 | 5.45e-30 | 174-403 | Nuclear receptor ligand-binding domain |
F54B8.2 | 1.44e-38 | 23-249 | Nuclear receptor ligand-binding domain |
F57A10.5 | 1.57e-47 | 238-420 | Nuclear receptor ligand-binding domain |
F57A8.5 | 2.83e-38 | 148-351 | Nuclear receptor ligand-binding domain |
F57G8.6 | 1.56e-36 | 152-378 | Nuclear receptor ligand-binding domain |
F58G6.5 | 3.93e-43 | 221-447 | Nuclear receptor ligand-binding domain |
F59E11.11 | 9.96e-35 | 175-418 | Nuclear receptor ligand-binding domain |
GO.102127 | 6.03e-91 | 10-304 | Nuclear receptor ligand-binding domain |
GO.103306 | 4.08e-91 | 10-304 | Nuclear receptor ligand-binding domain |
GO.111246 | 4.4e-88 | 10-257 | Nuclear receptor ligand-binding domain |
GO.45105 | 9.96e-65 | 26-40,82-322 | Nuclear receptor ligand-binding domain |
GO.81824 | 9.71e-65 | 229-469 | Nuclear receptor ligand-binding domain |
G_YK4041 | 6.55e-46 | 172-389 | Nuclear receptor ligand-binding domain |
G_YK8564 | 2.49e-33 | 166-413 | Nuclear receptor ligand-binding domain |
G_YK8799 | 2.23e-51 | 93-341 | Nuclear receptor ligand-binding domain |
H01A20.1 | 2.23e-28 | 228-459 | Nuclear receptor ligand-binding domain |
H10E21.3 | 4.46e-38 | 233-464 | Nuclear receptor ligand-binding domain |
H12C20.3 | 3.28e-40 | 152-381 | Nuclear receptor ligand-binding domain |
H22D14.1 | 6.12e-23 | 152-336 | Nuclear receptor ligand-binding domain |
HR3061 | 1.07e-70 | 152-407 | Nuclear receptor ligand-binding domain |
HR3061A | 6.03e-70 | 12-239 | Nuclear receptor ligand-binding domain |
HR3061C | 3.67e-62 | 2-183 | Nuclear receptor ligand-binding domain |
HR4464 | 1.7e-82 | 240-503 | Nuclear receptor ligand-binding domain |
HR4469 | 6.42e-64 | 259-485 | Nuclear receptor ligand-binding domain |
HR4533 | 3.02e-63 | 530-776 | Nuclear receptor ligand-binding domain |
HR4563 | 6.42e-70 | 305-544 | Nuclear receptor ligand-binding domain |
HR4643 | 5.77e-83 | 201-458 | Nuclear receptor ligand-binding domain |
HR4675 | 1.1e-62 | 617-643,674-913 | Nuclear receptor ligand-binding domain |
HR4685 | 2.75e-63 | 262-498 | Nuclear receptor ligand-binding domain |
HR4725 | 1.7e-65 | 673-917 | Nuclear receptor ligand-binding domain |
HR4734 | 1.84e-59 | 147-376 | Nuclear receptor ligand-binding domain |
HR4751 | 4.72e-84 | 189-457 | Nuclear receptor ligand-binding domain |
HR4793 | 1.07e-65 | 338-596 | Nuclear receptor ligand-binding domain |
HR4801 | 5.11e-71 | 315-547 | Nuclear receptor ligand-binding domain |
HR6377 | 3.54e-71 | 145-400 | Nuclear receptor ligand-binding domain |
IGBMC-0005-000 | 1.26e-69 | 315-547 | Nuclear receptor ligand-binding domain |
IGBMC-0006-000 | 2.75e-63 | 262-498 | Nuclear receptor ligand-binding domain |
IGBMC-0007-000 | 2.75e-71 | 2-242 | Nuclear receptor ligand-binding domain |
IGBMC-0008-000 | 1.97e-87 | 12-276 | Nuclear receptor ligand-binding domain |
IGBMC-0009-000 | 5.9e-70 | 12-251 | Nuclear receptor ligand-binding domain |
IGBMC-0010-000 | 1.44e-64 | 14-250 | Nuclear receptor ligand-binding domain |
IGBMC-0012-000 | 2.88e-75 | 137-415 | Nuclear receptor ligand-binding domain |
IGBMC-0014-000 | 1.3e-72 | 334-596 | Nuclear receptor ligand-binding domain |
IGBMC-0017-000 | 5.77e-83 | 201-458 | Nuclear receptor ligand-binding domain |
IGBMC-0018-000 | 2.1e-77 | 175-457 | Nuclear receptor ligand-binding domain |
IGBMC-0019-000 | 2.1e-77 | 175-457 | Nuclear receptor ligand-binding domain |
IGBMC-0058-000 | 9.96e-74 | 7-240 | Nuclear receptor ligand-binding domain |
IGBMC-0059-000 | 2.49e-71 | 4-225 | Nuclear receptor ligand-binding domain |
IGBMC-0062-000 | 2.1e-62 | 226-252,281-519 | Nuclear receptor ligand-binding domain |
IGBMC-0078-000 | 1.03e-102 | 178-416 | Nuclear receptor ligand-binding domain |
IGBMC-0086-000 | 8.91e-73 | 302-534 | Nuclear receptor ligand-binding domain |
IGBMC-0087-000 | 4.33e-76 | 136-402 | Nuclear receptor ligand-binding domain |
IGBMC-0089-000 | 3.8e-71 | 438-652 | Nuclear receptor ligand-binding domain |
IGBMC-0090-000 | 1.17e-68 | 305-528 | Nuclear receptor ligand-binding domain |
IGBMC-0091-000 | 4.46e-67 | 246-495 | Nuclear receptor ligand-binding domain |
IGBMC-0092-000 | 5.51e-70 | 272-511 | Nuclear receptor ligand-binding domain |
IGBMC-0093-000 | 3.02e-70 | 210-450 | Nuclear receptor ligand-binding domain |
IGBMC-0094-000 | 5.9e-58 | 272-504 | Nuclear receptor ligand-binding domain |
IGBMC-0106-000 | 3.15e-66 | 282-543 | Nuclear receptor ligand-binding domain |
IGBMC-0107-000 | 1.04e-70 | 219-479 | Nuclear receptor ligand-binding domain |
IGBMC-0108-000 | 4.06e-67 | 211-458 | Nuclear receptor ligand-binding domain |
IGBMC-0110-000 | 3.15e-72 | 453-671 | Nuclear receptor ligand-binding domain |
IGBMC-0111-000 | 1.97e-72 | 352-570 | Nuclear receptor ligand-binding domain |
IGBMC-0112-000 | 2.62e-71 | 229-443 | Nuclear receptor ligand-binding domain |
IGBMC-0113-000 | 1.48e-91 | 124-422 | Nuclear receptor ligand-binding domain |
IGBMC-0114-000 | 1.34e-85 | 156-448 | Nuclear receptor ligand-binding domain |
IGBMC-0115-000 | 1.97e-84 | 167-435 | Nuclear receptor ligand-binding domain |
IGBMC-1003-000 | 3.8e-78 | 137-415 | Nuclear receptor ligand-binding domain |
IGBMC-1013-000 | 1.07e-65 | 338-596 | Nuclear receptor ligand-binding domain |
IGBMC-1014-000 | 6.03e-56 | 365-626 | Nuclear receptor ligand-binding domain |
IGBMC-1015-000 | 8e-68 | 169-195,223-460 | Nuclear receptor ligand-binding domain |
IGBMC-1016-000 | 1.97e-70 | 174-432 | Nuclear receptor ligand-binding domain |
IGBMC-1017-000 | 3.41e-67 | 152-166,301-539 | Nuclear receptor ligand-binding domain |
IGBMC-1018-000 | 2.1e-60 | 59-94,220-459 | Nuclear receptor ligand-binding domain |
IGBMC-1019-000 | 8.91e-50 | 145-156,247-481 | Nuclear receptor ligand-binding domain |
IGBMC-1020-000 | 9.58e-65 | 229-469 | Nuclear receptor ligand-binding domain |
K06A1.4 | 2.62e-41 | 235-242,346-575 | Nuclear receptor ligand-binding domain |
K06B4.1 | 9.57e-43 | 94-335 | Nuclear receptor ligand-binding domain |
K06B4.2 | 1.2e-40 | 102-335 | Nuclear receptor ligand-binding domain |
K06B4.5 | 2.75e-41 | 87-325 | Nuclear receptor ligand-binding domain |
K06B4.7 | 3.02e-41 | 98-336 | Nuclear receptor ligand-binding domain |
K06B4.8 | 2.75e-42 | 119-350 | Nuclear receptor ligand-binding domain |
K08A2.7 | 1.44e-34 | 193-420 | Nuclear receptor ligand-binding domain |
K08A2.A | 1.44e-34 | 193-420 | Nuclear receptor ligand-binding domain |
K08H2.8 | 1.7e-29 | 172-411 | Nuclear receptor ligand-binding domain |
K10C3.6 | 3.41e-48 | 5-27,185-395 | Nuclear receptor ligand-binding domain |
K12H6.1 | 5.24e-30 | 179-372 | Nuclear receptor ligand-binding domain |
M02H5.1 | 3.17e-37 | 160-416 | Nuclear receptor ligand-binding domain |
M02H5.7 | 6.97e-35 | 166-406 | Nuclear receptor ligand-binding domain |
NYSGXRC-T307 | 1.44e-29 | 357-640 | Nuclear receptor ligand-binding domain |
R02D1.1 | 1.09e-35 | 158-361 | Nuclear receptor ligand-binding domain |
R04B5.3 | 2.82e-26 | 135-382 | Nuclear receptor ligand-binding domain |
R04B5.4 | 6.3e-37 | 188-449 | Nuclear receptor ligand-binding domain |
R07B7.14 | 2.23e-39 | 172-404 | Nuclear receptor ligand-binding domain |
R07B7.15 | 1.57e-39 | 165-409 | Nuclear receptor ligand-binding domain |
R09G11.2B | 1.1e-42 | 217-422 | Nuclear receptor ligand-binding domain |
R11G11.1 | 0.00000000000000104 | 163-270 | Nuclear receptor ligand-binding domain |
T01B10.4A | 7.34e-37 | 135-341 | Nuclear receptor ligand-binding domain |
T01G6.5 | 2.18e-30 | 149-378 | Nuclear receptor ligand-binding domain |
T01G6.6 | 2.02e-31 | 176-399 | Nuclear receptor ligand-binding domain |
T01G6.8 | 3.74e-40 | 206-438 | Nuclear receptor ligand-binding domain |
T03E6.3 | 8.83e-18 | 116-185,222-362 | Nuclear receptor ligand-binding domain |
T05B4.2 | 4.54e-32 | 133-372 | Nuclear receptor ligand-binding domain |
T06C12.13 | 1.4e-36 | 167-413 | Nuclear receptor ligand-binding domain |
T06C12.7 | 1.43e-29 | 19-24,169-414 | Nuclear receptor ligand-binding domain |
T07C5.3 | 8.91e-39 | 78-308 | Nuclear receptor ligand-binding domain |
T09A12.4 | 5.51e-29 | 456-686 | Nuclear receptor ligand-binding domain |
T13F3.3 | 6.59e-22 | 133-352 | Nuclear receptor ligand-binding domain |
T19A5.4 | 3.87e-36 | 180-424 | Nuclear receptor ligand-binding domain |
T20C7.A | 1.36e-22 | 23-158 | Nuclear receptor ligand-binding domain |
T26H2.9 | 2.49e-27 | 212-460 | Nuclear receptor ligand-binding domain |
T27B7.1 | 9.65e-31 | 179-412 | Nuclear receptor ligand-binding domain |
T27B7.3 | 4.98e-41 | 157-383 | Nuclear receptor ligand-binding domain |
T27B7.6 | 2.02e-43 | 166-392 | Nuclear receptor ligand-binding domain |
W00599 | 2.1e-67 | 28-267 | Nuclear receptor ligand-binding domain |
W01D2.2A | 3.41e-25 | 173-403 | Nuclear receptor ligand-binding domain |
W05B5.3 | 3.8e-17 | 211-417 | Nuclear receptor ligand-binding domain |
WR126 | 2.36e-18 | 14-124 | Nuclear receptor ligand-binding domain |
Y110A2B.A | 5.24e-30 | 179-372 | Nuclear receptor ligand-binding domain |
Y15E3A.1 | 6.03e-30 | 170-453 | Nuclear receptor ligand-binding domain |
Y17D7A.3 | 8.85e-36 | 143-396 | Nuclear receptor ligand-binding domain |
Y17D7B.1 | 1.12e-18 | 361-485 | Nuclear receptor ligand-binding domain |
| 7.29e-18 | 146-319 | Nuclear receptor ligand-binding domain |
Y22F5A.1 | 5.55e-31 | 175-388 | Nuclear receptor ligand-binding domain |
Y38E10A.18 | 1.36e-21 | 171-355 | Nuclear receptor ligand-binding domain |
Y38E10A.19 | 4.13e-18 | 8-211 | Nuclear receptor ligand-binding domain |
Y38F2AL.B | 0.00000000484 | 47-192 | Nuclear receptor ligand-binding domain |
Y39B6A.17A | 2.77e-34 | 152-369 | Nuclear receptor ligand-binding domain |
Y46H3D.6 | 5.73e-27 | 91-328 | Nuclear receptor ligand-binding domain |
Y51A2D.17 | 1.48e-45 | 77-103,131-386 | Nuclear receptor ligand-binding domain |
Y5H2B.2 | 4.98e-36 | 179-410 | Nuclear receptor ligand-binding domain |
Y67A6A.2 | 3.41e-34 | 264-505 | Nuclear receptor ligand-binding domain |
Y67D8B.B | 8.99e-27 | 82-315 | Nuclear receptor ligand-binding domain |
Y77E11A.5 | 2.7e-22 | 213-380,412-456 | Nuclear receptor ligand-binding domain |
Y80D3A.4 | 1.24e-34 | 230-461 | Nuclear receptor ligand-binding domain |
Y94H6A.J | 7.34e-27 | 232-465 | Nuclear receptor ligand-binding domain |
ZC410.1 | 2.62e-39 | 192-458 | Nuclear receptor ligand-binding domain |
ZK1025.10 | 0.00000000000000115 | 128-324 | Nuclear receptor ligand-binding domain |
ZK1025.6 | 8.22e-17 | 12-170 | Nuclear receptor ligand-binding domain |
ZK1025.9 | 3.37e-21 | 2-174 | Nuclear receptor ligand-binding domain |
ZK381.3 | 0.000000000272 | 3-111 | Nuclear receptor ligand-binding domain |
ZK418.1 | 1.28e-45 | 100-331 | Nuclear receptor ligand-binding domain |
ZK488.2 | 9.65e-39 | 162-385 | Nuclear receptor ligand-binding domain |
ZK488.4 | 2.82e-16 | 162-340 | Nuclear receptor ligand-binding domain |
ZK6.4 | 5.24e-50 | 97-340 | Nuclear receptor ligand-binding domain |
ZK697.2 | 7.47e-22 | 180-428 | Nuclear receptor ligand-binding domain |
|
Weak hits: |
281972 | 0.0608 | 6-66 | Nuclear receptor ligand-binding domain |
357445 | 0.0464 | 29-75 | Nuclear receptor ligand-binding domain |
374243 | 0.0646 | 23-73 | Nuclear receptor ligand-binding domain |
393165 | 0.0457 | 246-281 | Nuclear receptor ligand-binding domain |
4116 | 0.0178 | 1049-1122 | Nuclear receptor ligand-binding domain |
419262 | 0.0178 | 250-275 | Nuclear receptor ligand-binding domain |
419378 | 0.0723 | 249-274 | Nuclear receptor ligand-binding domain |
C32F10.6 | 0.00184 | 162-353 | Nuclear receptor ligand-binding domain |
ChR73 | 0.0596 | 86-172 | Nuclear receptor ligand-binding domain |
K02B12.2 | 0.0663 | 20-79 | Nuclear receptor ligand-binding domain |
Lmaj00846AAB | 0.0268 | 18-59 | Nuclear receptor ligand-binding domain |
NYSGRC-CAA58351 | 0.0169 | 194-293 | Nuclear receptor ligand-binding domain |